Highlighting 10 innovative late-stage BioPharma drugs with the potential to reshape treatment paradigms and industry dynamics ...

Bryan Johnson livestreamed his shrooms trip -- which included both Grimes and Marc Benioff -- as part of his controversial ...

Here are some do’s and don’ts on using AI for schoolwork: Chatbots are so good at answering questions with detailed written ...

The best comedy of 2025 includes specials by Frankie Quiñones, Andrew Schulz, Jordan Jensen, Sebastian Maniscalco, Bill Burr, ...

This potentially valuable cross-sectional longitudinal study leverages high-definition transcranial direct current stimulation to the left dorsolateral prefrontal cortex to examine its effect on ...

Laughing matters. It always has. But laughing may matter even more in modern times. Does anyone think that during the Middle Ages, or even in the late 19th century, ordinary citizens spent as much ...

—Long-term Phase 1/2a and open label extension (OLE) data for zorevunersen on top of standard of care anti-seizure medicines (ASMs) demonstrate durable seizure reductions, including increases in ...

Discusses Clinical Progress of Lead Drug Candidates Targeting Parkinson's, Alzheimer's, and Liver Disease December 9, 2025 4:15 ...

To date, ETX101 has shown a favorable safety profile and has been well-tolerated across all four dose levels with no treatment-related serious adverse events (n=19). The most common treatment-related ...

Laughing matters. It always has. But laughing may matter even more in modern times. Does anyone think that during the Middle Ages, or even in the late 19th century, ordinary citizens spent as much ...

Long-term Phase 1/2a and open label extension (OLE) data for zorevunersen on top of standard of care anti-seizure medicines (ASMs)demonstrate ...

Long-term LEQEMBI treatment suggests potential to delay disease progression from Mild Cognitive Impairment (MCI) to moderate Alzheimer’s disease by up to 8.3 years in low-amyloid group who started ...